Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease

British journal of clinical pharmacology

Volumn 78, Issue 4, 2014, Pages 789-799

  Mose, Frank H olden ^a   Larsen, Thomas ^a   Jensen, Janni M ajgaard ^a   Hansen, Annebirthe B o ^a   Bech, Jesper N ørgaard ^a   Pedersen, Erling B jerregaard ^a  

^a HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

atorvastatin; chronic kidney disease; epithelial sodium channels; fractional excretion of sodium; nitric oxide

Indexed keywords

ATORVASTATIN; EPITHELIAL SODIUM CHANNEL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE; PYRROLE DERIVATIVE;

ADULT; AGED; ARTERIAL STIFFNESS; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATORVASTATIN CALCIUM; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPITHELIAL SODIUM CHANNELS; FEMALE; GLOMERULAR FILTRATION RATE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY; MALE; MIDDLE AGED; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PYRROLES; RENAL INSUFFICIENCY, CHRONIC; VASCULAR STIFFNESS;

EID: 84964314129     PISSN: None     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12390     Document Type: Article

References (0)